Hypopituitarism-microphthalmia syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2244
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hypopituitarism-microphthalmia syndrome is an extremely rare condition that combines problems with the pituitary gland (a small gland at the base of the brain that produces important hormones) and abnormally small eyes (microphthalmia). The pituitary gland is sometimes called the 'master gland' because it controls many other glands in the body. When it does not work properly (hypopituitarism), the body may not produce enough growth hormone, thyroid hormone, cortisol, or other critical hormones. This can lead to slow growth, delayed puberty, low energy, and other hormonal problems. The eye abnormality, microphthalmia, means one or both eyes are unusually small and may have reduced vision or even blindness. Some patients may also have other developmental differences, including brain abnormalities or intellectual challenges. This syndrome is sometimes referred to as 'Lenz microphthalmia syndrome' in certain contexts, though the exact genetic and clinical overlap with other microphthalmia syndromes can vary. Treatment focuses on replacing the missing hormones through lifelong hormone replacement therapy and managing vision problems with appropriate eye care. Because the condition is so rare, management is best handled by a team of specialists who can address both the hormonal and eye-related aspects of the disease. Early diagnosis and treatment of hormone deficiencies are important for supporting normal growth and development in affected children.

Also known as:

Key symptoms:

Abnormally small eyes (one or both)Poor vision or blindnessShort stature or slow growthDelayed pubertyLow energy and fatigueLow thyroid hormone levelsLow cortisol levelsGrowth hormone deficiencyPossible intellectual disabilityPossible brain structure abnormalitiesLow blood sugar episodes in infancyDifficulty gaining weight in infancyPossible genital underdevelopment in boys

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hypopituitarism-microphthalmia syndrome.

View clinical trials →

No actively recruiting trials found for Hypopituitarism-microphthalmia syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hypopituitarism-microphthalmia syndrome community →

No specialists are currently listed for Hypopituitarism-microphthalmia syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hypopituitarism-microphthalmia syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hypopituitarism-microphthalmia syndromeForum →

No community posts yet. Be the first to share your experience with Hypopituitarism-microphthalmia syndrome.

Start the conversation →

Latest news about Hypopituitarism-microphthalmia syndrome

No recent news articles for Hypopituitarism-microphthalmia syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which specific hormones are affected in my child, and what replacement therapies are needed?,How should we handle hormone dosing during illness or emergencies (stress dosing)?,What is the expected level of vision in my child, and what support services are available?,Should we pursue genetic testing, and what genes should be tested?,How often will my child need blood tests and imaging to monitor hormone levels?,Are there any clinical trials or research studies we should know about?,What developmental or educational support should we arrange for my child?

Common questions about Hypopituitarism-microphthalmia syndrome

What is Hypopituitarism-microphthalmia syndrome?

Hypopituitarism-microphthalmia syndrome is an extremely rare condition that combines problems with the pituitary gland (a small gland at the base of the brain that produces important hormones) and abnormally small eyes (microphthalmia). The pituitary gland is sometimes called the 'master gland' because it controls many other glands in the body. When it does not work properly (hypopituitarism), the body may not produce enough growth hormone, thyroid hormone, cortisol, or other critical hormones. This can lead to slow growth, delayed puberty, low energy, and other hormonal problems. The eye abno

At what age does Hypopituitarism-microphthalmia syndrome typically begin?

Typical onset of Hypopituitarism-microphthalmia syndrome is neonatal. Age of onset can vary across affected individuals.